Annual CFO:
-$4.00M+$961.20K(+19.37%)Summary
- As of today (October 4, 2025), RGC annual cash from operations is -$4.00 million, with the most recent change of +$961.20 thousand (+19.37%) on June 30, 2024.
- During the last 3 years, RGC annual cash from operations has fallen by -$3.23 million (-421.53%).
- RGC annual cash from operations is now -923.45% below its all-time high of -$391.00 thousand, reached on June 30, 2019.
Performance
RGC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RGC Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +19.4% | - | - |
| 3Y3 Years | -421.5% | - | - |
| 5Y5 Years | -923.5% | - | - |
RGC Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +24.0% | ||||
| 5Y | 5-Year | -450.7% | +24.0% | ||||
| All-Time | All-Time | -923.5% | +24.0% |
RGC Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | -$4.00M(-19.4%) | - | - |
| Jun 2023 | -$4.96M(-5.8%) | - | - |
| Jun 2022 | -$5.27M(+586.4%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | -$767.30K(+5.6%) | - | - |
| Jun 2020 | -$726.60K(+85.8%) | - | - |
| Jun 2019 | -$391.00K | - | - |
FAQ
- What is Regencell Bioscience Holdings Limited annual cash from operations?
- What is the all-time high annual cash from operations for Regencell Bioscience Holdings Limited?
- What is Regencell Bioscience Holdings Limited annual cash from operations year-on-year change?
What is Regencell Bioscience Holdings Limited annual cash from operations?
The current annual cash from operations of RGC is -$4.00M
What is the all-time high annual cash from operations for Regencell Bioscience Holdings Limited?
Regencell Bioscience Holdings Limited all-time high annual cash from operations is -$391.00K
What is Regencell Bioscience Holdings Limited annual cash from operations year-on-year change?
Over the past year, RGC annual cash from operations has changed by +$961.20K (+19.37%)